FDA Compounding Quality Center of Excellence: Ten Years of Regulated Outsourcing Facilities: A Decade of Progress, But More to Do – (Sept. 11th-13th) Virtual Conference
The MediZap team spent 3 days engaged in all virtual meeting topics and have created a downloadable PDF document that incorporates highlights and learnings we have gathered from this conference.
Topics included:
Prohibition on wholesaling under section 503B of the Federal Food, Drug, and Cosmetic Act
Stakeholder Perspective: 503Bs as Partners to Providers: Benefits and Challenges
Quality Throughout the Supply Chain
Drug Shortages
Managing State Regulatory Challenges
Stakeholder Perspective: Purchasing and Forecasting: How it Works